← Open Payments lookup

JESSICA ADWELL: Open Payments

NPI 1043833726 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,742 in 89 payments from 14 companies in 2025. Trend: 2023 $2,104 · 2024 $1,731 · 2025 $1,742

Food & beverage: $1,632Education: $109
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.12$282
Vanda Pharmaceuticals Inc.9$240
Neurocrine BioSciences, Inc.7$215
Otsuka America Pharmaceutical, Inc.14$180
ABBVIE INC.15$172
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$169
Corium, LLC4$109
Lundbeck LLC4$107
Supernus Pharmaceuticals, Inc.4$81
Otsuka Pharmaceutical Development & Commercialization, Inc.2$54

Products named: REXULTI, FANAPT, INGREZZA, AUSTEDO XR, VRAYLAR, CAPLYTA, Azstarys, Qelbree.

Industry payments across AL — which companies pay providers there.